Literature DB >> 26511023

[Case of posterior reversible encephalopathy syndrome due to azathioprine].

Ryo Ogawa1, Takanori Oikawa, Tomomi Shijo, Shigenori Kanno, Satoshi Shibuya, Hiroshi Mochizuki.   

Abstract

This report describes a 15-year-old woman presenting posterior reversible encephalopathy syndrome (PRES) due to azathioprine. She was under treatment for ulcerative colitis. She was prescribed azathioprine seven days before admission. Four days after, she complained of headache. Then, she disturbed consciousness and showed generalized convulsive seizure on the day of admission. Magnetic resonance imaging (MRI) revealed vasogenic edema in both hemispheres. She was discontinued azathioprine and treated by anticonvulsant. Her symptoms were recovered and the MRI findings were disappeared. We diagnosed as PRES due to azathioprine because of clinical course and MRI findings. Only one case of PRES due to azathioprine is reported previously. Our case is the first report that showed the changes and improvement of MRI findings along the clinical course.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26511023     DOI: 10.5692/clinicalneurol.cn-000733

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  1 in total

1.  Recurring posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis.

Authors:  Masaki Kobatake; Naoto Ishimaru; Yohei Kanzawa; Hiroyuki Seto; Saori Kinami
Journal:  Eur J Rheumatol       Date:  2019-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.